How your Mova Medical weight loss journey works…

Weight Management for you.

At Mova Medical we offer an individualised personal service to help you achieve your lifestyle and health goals including prescribed weight loss medicine direct to your door.

Your clinician will determine whether you are suitable for treatment from your responses. If successful we will decide which weekly injectable medicine is preferable for you.

Whatever level of support you choose, we will assist you to make positive changes to your health and wellbeing by helping you to develop healthier food choices and eating habits and be more active to achieve your personal goals. Check out our Blog.

4 Steps to the New You.

A woman with dark brown hair and hoop earrings sitting at a wooden table, using a silver laptop with a white mug in her left hand, in a room with light-colored curtains and a bookshelf in the background.
  1. Do a little Preparation…

We’ll need your BMI and waist measurements before you fill in your consultation form which are easily done with our measure page here.

So you need…

  1. Waist measurement and BMI to full in on the consultation form

  2. Valid Photo Identity such as a copy of a Passport or Driving Licence you can submit this to info@movamedical.co.uk with your name as the ‘Subject.’

    You can start your consultation process by clicking the Fresha button at the bottom of this page.

A person participating in a video call on a laptop, with a woman on the screen and the word 'mova.' displayed in the top left corner.

2. Book Your Consultation!

The first step! Schedule a video consultation - (you’ll see the Fresha button on this page). Please ensure your chosen date allows us a few days before the video to review your answers from the consultation form link you will be sent.

At your video consultation your clinician will listen to understand more about your health now, your reasons for wanting to lose weight and your previous health history from your answers. With your clinician you will agree a realistic goal for weight loss and come away with a clear strategy for achieving your goal.

Consultations take up to 30 minutes.

Any follow up review consultations will be agreed at your initial consultation.

Two medical pens, one white Wegovy FlexTouch and one gray Munjaro KwikPen, lying on a pink patterned background.

3. We provide the best plan for you.

Based on our findings we’ll recommend the best treatments for you.

You can see an indication of our prices by clicking the Q&A at the bottom of the page.

There are differences between Wegovy and Mounjaro so we will choose the medication and dosage to optimise the results you achieve and find the best fit for you. Wegovy and Mounjaro are supplied as pre-loaded injection pens. Single Dose is 1 months supply and 1 pen. Double Dose is 2 months supply and 2 pens. Each pen contains 4 pre-measured quick and easy once a week injections.

Black door with a gold mail slot and a gold doorbell.

4. Your medicine arrives by post.

Your medically prescribed weight loss medicine arrives under plain packaging through your door each month.

Your prescriber Erika can suggest recommended lifestyle changes from diet, to portion size and gentle exercise.

Check out our Blog page for regular updates to help you on your weight loss journey.

  1. Please note that weight loss medication will only be prescribed where safe and clinically appropriate. The suitability of a particular medicine as part of a weight-management service carries a professional duty of care that is mutually agreed through a shared discussion with you and your clinician.

  2. Follow up review consultations are £25. The frequency of these is agreed with you and your clinician during your initial remote video consultation. They need to be at least annually, or at 3 months if you are new to weight loss medication. Please allow around 15-20 minutes. The cost will be deducted from your next prescription once. Hence we need to be able to annotate a client’s record of this in some way so its clear. Its only the subsequent prescription x 1 that the cost of the follow-up consultation is deducted.

Fresha logo featuring a purple circle and the word 'fresha' in black lowercase letters.
A woman in a yellow long-sleeve shirt adjusting her smartwatch outdoors.

Useful information

  • Your clinician will ask questions about your current health and health history obtained from your on-line consultation submission. Time will be taken to explore goals and strategies to support you with success and discuss questions you may have about any aspect of our service or weight loss medicines.

  • At Mova Medical we can prescribe weight loss medicines only after a comprehensive health history has been obtained through your on-line consultation submission and during the remote video consultation providing the appropriate criteria are met.

    Please note not everyone is eligible to take weight loss medication and it will only be prescribed in accordance with the regulatory framework for its UK license.

  • Mounjaro, is also a once-weekly injectable medication, licensed for weight loss that contains the active ingredient tirzepatide. Similar to Wegovy, Mounjaro achieves weight loss through its novel mechanism of action to suppress appetite, so you eat less. It mimics the action of a 2 hormones GIP and GLP-1, Wegovy only mimics the GLP-1 receptor. GIP and GLP-1 are released after eating and slows down the movement of food in your gut so you remain full for longer. Both GIP and GLP-1 receptors are also found in areas of the human brain important for appetite regulation.

    The amount of weight you lose on Mounjaro will depend on your personal circumstances, your motivation to lose weight, your diet and lifestyle and how long you take the medication.

  • Similar to Wegovy the dose is gradually titrated at no less frequently than monthly.

    The titration steps are:

    • Weeks 1-4: 2.5mg once-weekly

    • Weeks 5-8: 5mg once-weekly

    • Weeks 9-12: 10mg once-weekly

    • Weeks 13-16: 12.5mg once-weekly

    • Weeks 17 onwards: 15mg once-weekly

  • Mounjaro in two pivotal clinical trials have demonstrated significant and superior weight loss compared to placebo.

    Surmount-31 evaluated the safety and efficacy of Mounjaro compared to placebo for 72 weeks after a 12-week low-calorie, diet, exercise and weekly counselling sessions intervention lead-in period, in adults with a BMI ≥30 or 27 and at least one weight -related co-morbidity, excluding Type 2 diabetes. At the end of the 12-week lead-in period participants achieved a mean weight loss of 6.9%. During the ensuing 72-week treatment period those taking Mounjaro lost an additional mean weight loss of 21.1% , corresponding to mean weight loss of 26.6% over the 84-week study period. Those taking placebo regained a mean weight of 3.3% over the same period.

    Surmount-42 evaluated the efficacy and safety of Mounjaro compared to placebo for 52 weeks after a 36-week open-label Mounjaro in adults with similar baseline characteristics to SURMOUNT-3. During the lead-in period all participants took Mounjaro and by the end of 36 weeks achieved a mean weight loss of 21.1%. For the next 52 weeks participants were randomised to Mounjaro or placebo. After a total of 88 weeks those taking Mounjaro demonstrated a mean total weight loss of 25.3%.

    The results of these 2 pivotal clinical trials correspond to a mean weight loss of 26kg and a mean reduction in waist circumference of 14.6cm in those taking Mounjaro.

  • As a dual GIP/GLP-1 agonist side effects are broadly similar to Wegovy but with added considerations due to its dual action side effects, notably gastrointestinal, that may potentially be more pronounced. A gradual dose titration can help to alleviate these gastrointestinal side effects.

    If you are prescribed Mounjaro more detailed information can be found in the Patient Information Leaflet included with each prescription you receive. It is advised you familiarise yourself with its content and retain a copy for future reference, renewing periodically as it can change as more information about its safety becomes known.

  • For all our pricing please see here.

  • Wegovy is a once-weekly injectable medication that contains the active ingredient semaglutide. Wegovy can achieve weight loss through its mechanism of action to suppress appetite, so you eat less. It mimics the action of a gut hormone called GLP-1 which is released after eating and slows down the movement of food in you gut so you remain full for longer.

    The amount of weight you lose on Wegovy will depend on your personal circumstances, your motivation to lose weight, your diet and lifestyle and how long you take the medication.

  • Wegovy injections are available in 5 strengths. A dose is taken once weekly. The dose prescribed will depend on where you are with your weight loss journey and agreed with your clinician at your remote video consultation.

    The dose is gradually increased no less frequently than monthly until you achieve a maintenance dose you are comfortable with. This is called titration and is done gradually to make sure you are able to manage potential side effects are for your safety.

    The titration steps are as follows:

    • Weeks 1-4: 0.25mg once-weekly

    • Weeks 5-8: 0.5mg once-weekly

    • Weeks 9-12: 1mg once-weekly

    • Weeks 13-16: 1.7mg once-weekly

    • Weeks 17 onwards: 2.4mg once-weekly

  • When Wegovy is combined with a reduced calorie diet and increased exercise a 68-week clinical trial1 demonstrated that the mean change in body weight at 68 weeks was 15% with 2.4mg Wegovy, corresponding to a mean weight loss of 15kg and a mean reduction in waist circumference of 13.5cm.

  • Nausea is the most common side effect of Wegovy. Other very common gastrointestinal side effects (occurring in at least 10% of people) include vomiting, diarrhoea, constipation and abdominal pain. These side effects can occur especially after starting Wegovy or during dose titration.

    Other very common non-gastrointestinal side effects include:

    • Fatigue

    • Headache

    • Injection site reactions – redness, swelling, pain.

    Less common but serious side effects include acute pancreatitis, gallbladder issues, potential thyroid C-cell tumour risk.

    If you are prescribed Wegovy more detailed information can be found in the Patient Information Leaflet included with each prescription you receive. It is advised you familiarise yourself with its content and retain a copy for future reference, renewing periodically as it can change as more information about its safety becomes known.

  • For all our pricing please see here.

What to expect on your weightloss journey

A notebook with

Up to 3 Months

It will take a few weeks for the medication to settle down then you’ll notice your hunger start to decrease as the medication takes effect.

A notebook with the words "Lost Weight" and an arrow pointing to the left, surrounded by sliced kiwi, half a passion fruit, and a yellow peach, with a yellow measuring tape around the notebook on a plain white background.

3 to 6 Months

You’ll find if you continue the medication programme and make some healthy lifestyle changes you’ll lose at least 10% of your weight.

A spiral notebook with the words 'Moving forward!' written on it, a yellow measuring tape, slices of kiwi and passion fruit, and a peach on a white surface.

Up to 1 year

Your controlled and steady weight loss continues. A new healthier YOU! Look at our blog for tips about healthy living!